NDC 57894-502-05
DARZALEX 100 mg/5mL
Daratumumab · INJECTION, SOLUTION, CONCENTRATE
DARZALEX is a injection, solution, concentrate containing daratumumab at a strength of 100 mg/5mL. Manufactured by Janssen Biotech, Inc..
Key Facts
- Brand Name
- DARZALEX
- Generic Name
- Daratumumab
- NDC Code (Package)
57894-502-05- NDC Code (Product)
57894-502- Manufacturer
- Janssen Biotech, Inc.
- Strength
- 100 mg/5mL
- Dosage Form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761036
- Drug Class
- CD38-directed Cytolytic Antibody [EPC]
- Marketing Start
- 11/16/2015
Recall History
No Recall HistoryView Full Drug Page
DARZALEX — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.